OTCBB:LIXT

Lixte Biotechnology Holdings Stock News

Healthcare > Biotechnology

Buy LIXT

*Your capital is at risk

$7.30

-0.180 (-2.41%)

At Close: Jun 23, 2026

LIXT Stock: 8 Things to Know About Lixte Biotechnology As Shares Blast Off

11:58am, Friday, 26'th Feb 2021

Lixte Biotechnology (LIXT) stock is heading higher on Friday with heavy trading of shares despite a lack of news concerning the company. The post LIXT Stock: 8 Things to Know About Lixte Biotechnology

Lixte Biotechnology to Present Its Anti-Cancer Therapy Enhancer LB-100 at the Virtual H.C. Wainwright Global Life Sciences Conference

09:35am, Wednesday, 24'th Feb 2021

EAST SETAUKET, NY, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc . (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in ca

Lixte Biotechnology and City of Hope to Initiate Phase 1b Clinical Trial of Lixte's Lead Compound LB-100 to Treat Small Cell Lung Cancer

09:35am, Tuesday, 19'th Jan 2021

EAST SETAUKET, NY, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc . (NASDAQ: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in ca

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by